Former NFL running back and Hall of Famer Terrell Davis is leveraging his public platform to raise awareness about tardive dyskinesia (TD), a neurological disorder often overlooked despite affecting hundreds of thousands in the United States. The campaign, in partnership with Teva Pharmaceuticals, highlights a lesser-known “TD” alongside the football abbreviation for “touchdown” and Davis’ own initials.
From Football Star to Mental Health Advocate
Davis’ involvement stems from his personal battles with mental health. He has openly discussed suicidal thoughts during periods of severe migraine headaches and acknowledged facing anxiety both on and off the field. This vulnerability led him to advocacy, realizing the power of shared experience in destigmatizing mental health struggles. As Davis explains, recognizing he wasn’t alone was the most impactful step in his journey.
His transformation from a player taught to suppress weakness to an advocate willing to share his pain underscores a broader shift in how mental health is perceived. The stigma ingrained in competitive environments often prevents individuals from seeking help, which Davis now aims to address.
The Connection to Tardive Dyskinesia
Davis’ mental health advocacy work naturally led him to learn about tardive dyskinesia. The condition, characterized by involuntary movements—twitching, restlessness, and often uncontrollable facial contortions—is a frequent side effect of long-term antipsychotic drug use. At least half a million Americans are affected. Davis isn’t the only celebrity to connect these issues; singer Carnie Wilson has also participated in awareness campaigns.
The link is significant because many people treated for mental health conditions are at risk for developing TD. The disorder isn’t just physical; it can be emotionally and socially debilitating.
Understanding the Risks and Delayed Onset
Tardive dyskinesia isn’t limited to antipsychotics. Antidepressants, mood stabilizers, anti-nausea drugs, and even decongestants can contribute. Critically, symptoms don’t appear immediately. A delay of months or even years between starting medication and onset is typical, meaning patients may not connect their movements to their treatment. Even after stopping the medication, TD often persists.
While dosage adjustments might help, self-medication is dangerous. Doctors can discuss options like VMAT inhibitors to manage symptoms. The biggest challenge remains undiagnosed cases: many patients suffer silently, unaware they have a treatable condition.
A Call for Open Dialogue
Terrell Davis’ involvement is strategic. As he puts it, “I have a voice,” one he intends to use for those who don’t. His career extends beyond the field; he’s been a commentator and even appeared on Sesame Street, giving him reach beyond sports fans. The goal is simple: increase awareness and encourage people to seek help if they suspect they have tardive dyskinesia. The message is clear—open dialogue and proper diagnosis are crucial for those affected.
